Cancer Treatment Informed by the Molecular Tumor Board At Dartmouth
Phase 2
192
about 5.8 years
18+
1 site in NH
About this study
Researchers are testing whether treatment recommendations from a Molecular Tumor Board impact how doctors make decisions about cancer treatment at Dartmouth Cancer Center. The trial will involve patients whose tumors are genetically profiled and who meet specific eligibility criteria. Doctors will be asked to complete surveys about how the Molecular Tumor Board's evaluation influenced their treatment choices.
Based on ClinicalTrials.gov records.
What participants do
- 1.Treatment recommendations made by Molecular Tumor Board
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Secondary: Number of participants with progression-free survival after Molecular Tumor Board recommendations were made., Time to treatment failure
Oncology